The CIS insulin market is segmented based on its application into type I Diabetes and Type II Diabetes. Type II Diabetes holds a dominant share, accounting for approximately 90% of the CIS insulin market. The presence of a wide range of products in the Type II Diabetes segment and the high prevalence of Type II Diabetes supplements the growth of this market. The CIS insulin market is further classified based on product types into rapid acting, long acting, short acting, intermediate acting and premixed. Long acting insulin accounts for the largest share in the CIS insulin market. The rapid acting insulin market is expected to grow faster in the near future. The CIS insulin market is also segmented on the basis of insulin sources into Analogs and Human Recombinant. The Analogs segment holds the dominant share in the CIS insulin market due to its high level of efficacy. The introduction of cutting edge products such as ultra fast analog and ultra long acting analog accelerates market growth. According to a geographic analysis of the CIS market, Russia is the largest market for insulin and accounted for 69.2% of the revenue generated in 2013. Ukraine is expected to grow faster due to untapped opportunities present in the region and the increasing number of government initiatives.
An in-depth analysis of various regions would provide a clear understanding of current and future trends so that companies can make region specific plans
Comprehensive analysis of the factors that drive and restrict the growth of the CIS insulin market is provided
Key regulatory guidelines in various regions which impact the CIS insulin market are critically examined
Quantitative analysis of the current market and estimations through 2013-2020 are provided to showcase the financial caliber of the CIS insulin market
Deep dive analysis of various regions provides insights that would enable companies to plan their business moves strategically
Value chain analysis in the report gives a clear understanding of the roles of the stakeholders involved in the supply chain of the CIS insulin market
The CIS insulin market is segmented based on its application, product type, source, and geography
Type I Diabetes
Type II Diabetes
By Product type
Rest of CIS
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.